Splenic cancer, which is a malignant tumor of the spleen, usually has a low incidence, with the more common form of splenic cancer being malignant lymphoma of the spleen.
Primary tumors of the spleen are rare, such as hemangioma, lymphangioma, malignant lymphoma, hemangioendothelial sarcoma and so on. Secondary ones are more common, such as hematologic leukemias, lymphomas, etc.
The cause of this type of disease is unknown, and patients with a family history of splenic tumors, recurrent infections with pathogens such as Mycobacterium avium and viruses, and long-term chronic injury to the spleen are more likely to develop splenic cancer. Patients often present with symptoms such as splenomegaly, discomfort in the left upper abdomen, nausea, vomiting and abdominal distension.
Due to the rich blood vessels and lymphatic vessels around the spleen, splenic cancer is easy to metastasize, so the spleen needs to be removed as early as possible, and the surrounding lymph nodes also need to be cleared when necessary. After surgery, chemotherapy can be supplemented with drugs such as doxorubicin and cyclophosphamide.
When patients are diagnosed with splenic cancer, they need to go to local hospitals for treatment as early as possible to avoid delaying the condition.